K. Balling

Administration of recombinant FVIIa (rFVIIa) to concizumab‐dosed monkeys is safe, and concizumab does not affect the potency of rFVIIa in hemophilic rabbits

B. Lauritzen, C. Augustsson, I. Hilden, 2019, Journal of thrombosis and haemostasis : JTH.

Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model.

A. Gruhler, J. Clausen, H. H. Petersen, 2012, Blood.

Functional characteristics of N8, a new recombinant FVIII

S. Lethagen, D. Viuff, E. Persson, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

The D 2194 G mutation is responsible for increased levels of FV 1 in carriers of the factor V R 2 haplotype

B. Dahlbäck, G. Nicolaes, T. Yamazaki, 2018 .

Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide.

T. Nichols, Henrik Østergaard, T. N. Krogh, 2011, Blood.

A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models.

L. Thim, H. Rahbek-Nielsen, E. Persson, 2013, Blood.

THROMBOSIS AND HEMOSTASIS A novel B-domain O-glycoPEGylated FVIII ( N 8-GP ) demonstrates full ef fi cacy and prolonged effect in hemophilic mice models

L. Thim, H. Rahbek-Nielsen, E. Persson, 2013 .

efficacy and prolonged effect in hemophilic mice models A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full

H. Rahbek-Nielsen, P. Johansen, F. Rode, 2013 .

Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide.

T. Nichols, Henrik Østergaard, F. Møller, 2011, Blood.